Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study

<div>Cumulative incidence of vascular events according to the pathogenesis of splanchnic vein thrombosis (a) and the presence of liver cirrhosis (b).</div>

Gastroenterology Research and Practice

fig3

Figure 3

Figure 3: Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study 

Figure 3 | Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study 